Congress and the FDA May Square Off Over CBD

Congress and the FDA May Square Off Over CBD

This past week, on Jan. 15, a bipartisan group of lawmakers in the House of Representatives introduced H.R. 5587, a bill that would amend the federal Food, Drug, and Cosmetic Act to classify hemp-derived CBD as a dietary supplement. 

https://www.fool.com/investing/2020/01/18/congress-and-the-fda-may-square-off-over-cbd.aspx

Industry News